 RANCHO CORDOVA, Calif., March 17, 2021 PRNewswire -- ThermoGenesis Holdings, Inc. Nasdaq: THMO, a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the year ended December 31, 2020 and provided a corporate strategic update. 